Royalty Pharma reports first quarter 2026 results

Go back to Royalty Pharma reports first quarter 2026 results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 52.96 --0 (-0%)
Previous Close $52.96    52 Week High $3.48 
Open $52.96    52 Week Low $0.80 
Day High $52.96    P/E N/A 
Day Low $52.96    EPS $-1.54 
Volume 12,779